Skip to content

Embosphere® 00884450403402Recalls & reported problems

Biosphere Medical · Class 2 · Implant

All models of Embosphere (18)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00884450403402), received between Jan 8, 2024 and Jan 8, 2024 — classified as 1 injury.

1 other recall cover devices cleared under the same FDA submission (K181300); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Abdominal Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 8, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE ACCOUNT ALLEGES POST A BILATERAL UTERINE ARTERY EMBOLIZATION PROCEDURE THE PATIENT EXPERIENCED SEVERE POSTOPERATIVE ABDOMINAL PAIN, WHICH REQUIRED ORAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, PTERIDINE INTRAMURAL INJECTION, AND MORPHINE SUBCUTANEOUS INJECTION FOR PAIN RELIEF. AFTER ABOVE TREATMENT, ABDOMINAL PAIN WAS GRADUALLY RELIEVED. NO ADDITIONAL INFORMATION AVAILABLE.

    Patient problems: Abdominal Pain

    MAUDE report 18466527 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K181300. One submission often covers many models, so check the product and lot details in each record.

  • Z-3305-2026 · Aug 10, 2026 · Open, Classified
    Embosphere 500-700 micrometer 2 mL Syringe Sterile Steam, REF: S420GH/EUA, S620GH/EUA; Embosphere 700-900 micrometer 2 mL Syringe Sterile Steam, REF: S820GH/CAB; Embosphere 900-

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page